NIH-funded research NIH-funded research

Mobile sun-safety and activity support for melanoma survivors

Official title: SESAME: Sun Exposure and Activities after Skin CAncer: Optimization of Mhealth IntErventions

Funded at Northwestern University · NIH-11192754 · Data updated 2026-11-12

This project uses smartphone tools to help melanoma survivors avoid harmful sun exposure while keeping up healthy physical activity.

More Skin Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorthwestern University
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 13, 2024
Project endAugust 31, 2027
Funding year2025
Award (this year)$319,854
NIH project number5R34CA283480-02
Project IDNIH-11192754 on NIH RePORTER

Who could benefit from this research

Could help

Adults who have survived melanoma, own a smartphone, and are willing to use a wearable activity monitor are the ideal candidates.

Less likely to help

People without a history of melanoma, those unwilling to use smartphone apps or wearables, or those unable to receive real-time messages are unlikely to benefit from this project.

What this research studies

You would use smartphone-based tools and wearable activity sensors that deliver real-time sun-protection advice. The team will refine different mobile components (like alerts, personalized tips, and activity tracking) using the Multiphase Optimization Strategy to find which elements reduce unprotected sun exposure without lowering outdoor exercise. The work focuses on adults who survived melanoma and combines sensor data (accelerometers) with user input to tailor messages. This R34 phase prepares the best mobile package for a larger clinical trial.

Why it matters

Potential benefit: If successful, the tools could reduce sunburns and lower the risk of new skin cancers while helping survivors maintain outdoor physical activity.

How similar studies have gone: Previous mobile health approaches for sun protection have been acceptable to melanoma survivors but have shown mixed effects, so this work is building on promising but inconsistent results.

Where this research is happening

  • Northwestern University
    Chicago, United States
    Active

Researchers

  • Principal investigator: Alshurafa, Nabil — Northwestern University
  • Study coordinator: Alshurafa, Nabil

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.